An open phase IV study for Indian patients (in between 18-65 years) suffering from Insomnia.
Phase 4
Completed
- Conditions
- Health Condition 1: G470- Insomnia
- Registration Number
- CTRI/2022/08/045113
- Lead Sponsor
- Eisai Pharmaceuticals India Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
1. Male or female aged 18 -65 years old (both inclusive) at the time of informed consent.
2. A clinical diagnosis of insomnia, as determined by the investigator
3. The decision to prescribe lemborexant for the patient has been made independently from the study participation.
Exclusion Criteria
1. Currently enrolled in another clinical study
2. Previously discontinued lemborexant treatment for any reason
3. Previously participated in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method